Theraclion SA
EPA:ALTHE.PA
0.351 (EUR) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.822 | 1.235 | 1.481 | 0.744 | 2.784 | 1.939 | 2.824 | 1.975 | 1.597 | 0.82 | 0.076 | 0 | 0.937 | 0.213 |
| Cost of Revenue
| 2.903 | 4.286 | 6.021 | 4.551 | 6.801 | 4.467 | 5.227 | 4.679 | 4.815 | 2.787 | 2.195 | 1.784 | 1.108 | 0.996 |
| Gross Profit
| -1.08 | -3.05 | -4.54 | -3.807 | -4.017 | -2.527 | -2.402 | -2.704 | -3.218 | -1.967 | -2.118 | -1.784 | -0.17 | -0.783 |
| Gross Profit Ratio
| -0.593 | -2.469 | -3.065 | -5.117 | -1.443 | -1.303 | -0.851 | -1.369 | -2.014 | -2.4 | -27.694 | -594,609 | -0.182 | -3.676 |
| Reseach & Development Expenses
| 0 | 4.3 | 3.82 | 2.1 | 3.6 | 3.6 | 3.8 | 3.2 | 2.6 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.014 | 3.102 | 0.224 | 0.479 | 0.59 | 2.558 | 2.888 | 4.296 | 3.524 | 2.48 | 2.054 | 0 | 0 | 0 |
| Other Expenses
| -1.08 | 0 | 0.027 | 0 | 0.086 | 0.001 | -0.167 | 0.037 | -0.151 | 0 | 0.183 | 1.862 | 1.913 | 1.503 |
| Operating Expenses
| -1.08 | 2.871 | 0.197 | 0.479 | 0.504 | 4.537 | 4.737 | 4.814 | 3.864 | 3.022 | 2.428 | 1.862 | 1.913 | 1.503 |
| Operating Income
| -3.154 | -6.307 | -4.737 | -4.286 | -4.521 | -6.977 | -7.098 | -7.487 | -7.241 | -4.959 | -4.547 | -3.646 | -2.084 | -2.286 |
| Operating Income Ratio
| -1.731 | -5.105 | -3.199 | -5.761 | -1.624 | -3.598 | -2.513 | -3.791 | -4.533 | -6.05 | -59.435 | -1,215,390.333 | -2.223 | -10.734 |
| Total Other Income Expenses Net
| -1.57 | 0.342 | 0.094 | -0.341 | -0.54 | -0.346 | -0.274 | -0.26 | 0.002 | -0.201 | 0.058 | -0.029 | 0.003 | -0.026 |
| Income Before Tax
| -4.724 | -5.966 | -4.643 | -4.627 | -5.061 | -7.323 | -7.372 | -7.748 | -7.239 | -5.16 | -4.488 | -3.675 | -2.081 | -2.312 |
| Income Before Tax Ratio
| -2.593 | -4.829 | -3.135 | -6.219 | -1.818 | -3.776 | -2.61 | -3.923 | -4.532 | -6.296 | -58.673 | -1,224,977 | -2.22 | -10.857 |
| Income Tax Expense
| -1.049 | 1.001 | -0.883 | -0.722 | -1.269 | 1.179 | 1.148 | 1.212 | 0.826 | 0.526 | -0.378 | -0.602 | -0.406 | -0.397 |
| Net Income
| -3.675 | -4.964 | -3.76 | -3.905 | -3.792 | -6.144 | -6.224 | -6.536 | -6.413 | -4.634 | -4.111 | -3.073 | -1.675 | -1.915 |
| Net Income Ratio
| -2.017 | -4.018 | -2.539 | -5.249 | -1.362 | -3.168 | -2.204 | -3.309 | -4.014 | -5.654 | -53.738 | -1,024,252 | -1.787 | -8.992 |
| EPS
| -0.08 | -0.17 | -0.17 | -0.24 | -0.25 | -0.73 | -0.83 | -1.01 | -1.58 | -1.32 | -1.44 | -1.03 | -0.56 | -0.64 |
| EPS Diluted
| -0.08 | -0.17 | -0.17 | -0.24 | -0.25 | -0.73 | -0.83 | -1.01 | -1.58 | -1.32 | -1.37 | -1.03 | -0.56 | -0.64 |
| EBITDA
| -4.487 | -6.163 | -4.404 | -4.15 | -4.48 | -6.623 | -6.735 | -7.169 | -6.866 | -4.655 | -4.245 | -3.207 | -1.734 | -1.978 |
| EBITDA Ratio
| -2.463 | -4.988 | -2.974 | -5.577 | -1.609 | -3.415 | -2.385 | -3.63 | -4.298 | -5.68 | -55.499 | -1,069,159 | -1.85 | -9.288 |